HPRT1 activates glycolysis to promote proliferation and metastasis of lung adenocarcinoma

Lung cancer remains one of the most formidable challenges in modern medicine, particularly a type called lung adenocarcinoma. This disease often hides until it has spread, leaving patients with few options for a cure. To understand how these tumors grow and spread, scientists look closely at how cancer cells feed themselves. Unlike healthy cells that burn fuel efficiently, cancer cells often switch to a faster, less efficient method of energy production called glycolysis. This process breaks down sugar to create energy and a byproduct called lactate, allowing the tumor to multiply rapidly even when oxygen is scarce. Researchers have long suspected that specific genes act as the switches turning this metabolic engine on, but identifying exactly which genes control this process in lung cancer has been difficult.

A team of researchers at the North China University of Science and Technology Affiliated Hospital set out to find one such switch. They focused on a gene called HPRT1. For a long time, scientists thought this gene was just a basic housekeeper, performing routine maintenance tasks inside every cell to keep them running. However, recent clues suggested it might play a more aggressive role in cancer. The researchers wanted to know if HPRT1 was actually driving the high-energy metabolism that allows lung cancer cells to grow and invade other parts of the body.

To investigate this, the team first looked at large databases of genetic information from thousands of lung cancer patients. By cross-referencing these records with known sugar-metabolism genes, they identified HPRT1 as a key player. Their analysis showed that patients with high levels of HPRT1 in their tumors had a much poorer outlook than those with lower levels. This statistical link suggested that the gene was not just a bystander but a driver of the disease. To test this idea directly, the scientists moved from computer data to the laboratory, working with human lung cancer cells grown in petri dishes.

They selected two types of lung cancer cells for their experiments: H1299 cells, which naturally have high levels of HPRT1, and A549 cells, which naturally have very low levels. The researchers created two scenarios to see what would happen. In the first, they silenced the HPRT1 gene in the H1299 cells, effectively turning the switch off. In the second, they forced the A549 cells to produce extra HPRT1, turning the switch up. The results were clear and consistent. When they reduced HPRT1, the cancer cells grew much slower, formed fewer colonies, and lost their ability to move and invade through barriers. Conversely, when they increased HPRT1, the cells multiplied faster and became far more aggressive, moving and invading with greater ease.

The team then asked how HPRT1 was causing these changes. They suspected the gene was boosting the cells' sugar-burning machinery. They measured the levels of lactate, the waste product of this sugar-burning process, and found that cells with high HPRT1 produced significantly more lactate. They also checked for specific enzymes that act as the gears in this metabolic machine, specifically two proteins known as HK2 and PKM2. They discovered that HPRT1 directly increased the amount of these enzymes. When HPRT1 was high, the gears turned faster, and the cells burned sugar more aggressively.

To prove that this sugar-burning process was the actual cause of the cancer's aggression, the researchers introduced a chemical blocker called 2-DG. This substance stops the cells from processing sugar. When they treated the aggressive, high-HPRT1 cells with this blocker, the cells stopped growing and invading. The chemical effectively neutralized the advantage the cancer cells had gained from having too much HPRT1. This experiment confirmed that HPRT1 does not just happen to be present in aggressive tumors; it actively drives their behavior by supercharging their sugar metabolism.

The study concludes that HPRT1 is a critical regulator of lung adenocarcinoma. It acts as a master switch that turns on the high-speed energy production cancer cells need to spread. While the research was conducted in the laboratory and not yet in patients, the findings suggest a new path for treatment. If doctors could find a way to block HPRT1 or stop the sugar metabolism it triggers, they might be able to slow down or stop the spread of this deadly disease. The work transforms our understanding of HPRT1 from a simple maintenance gene into a potential target for new therapies that could improve survival for those facing lung cancer.